Brown, I <br/><br/>
The development of a [211AT]-astatinated endoradiotherapeutic drug: part IV--late radiation effects.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  Mar 1998 
 - 1177-83 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0360-3016 
<br/><br/><label>Standard No.: </label>10.1016/s0360-3016(97)00907-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Astatine--adverse effects<br/>Dose-Response Relationship, Radiation<br/>Drug Screening Assays, Antitumor<br/>Lung--radiation effects<br/>Lymphoma--chemically induced<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Plasmacytoma--chemically induced<br/>Radiation Injuries, Experimental--mortality<br/>Radiopharmaceuticals--adverse effects<br/>Thyroid Gland--radiation effects